Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Shareholders' Equity

v3.19.1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Preferred Stock Including Additional Paid in Capital [Member]
Common Stock Including Additional Paid in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Mar. 25, 2017 18,534 9,594,203    
Balance at Mar. 25, 2017 $ 2,911 $ 24,390 $ (25,581) $ 1,720
Net loss (3,101) (3,101)
Restricted stock granted (in shares) 586,950    
Restricted stock forfeited (in shares) (236,000)    
Stock based compensation $ 251 251
Shares issued related to loan agreement (in shares) 367,500    
Shares issued related to loan agreement $ 224 224
Common stock issued to lender (in shares) 43,800    
Proceeds from issuance of Series E preferred stock, net of issuance costs $ 993 993
Repriced 2016 investor warrants (203) 203
Fair value of the warrants issued to EGE as issuance cost of Series E (54) 54
Repricing of warrants issued to EGE related to 2016 private placement (34) 34
Fair value of modified PFG warrants 44 44
Beneficial conversion feature (BCF) upon issuance of Series E preferred shares (557) 557
Deemed dividend of discount to Series E preferred shares resulting from recognition of BCF $ 557 $ (557)
Restricted stock forfeited (in shares) 236,000    
Balance (in shares) at Mar. 31, 2018 62,334 10,312,653    
Balance at Mar. 31, 2018 $ 3,613 $ 25,200 (28,682) 131
Net loss (1,043) (1,043)
Restricted stock granted (in shares) 310,000    
Restricted stock forfeited (in shares) 25,000    
Stock based compensation $ 245 245
Shares issued related to loan agreement (in shares) 30,000    
Shares issued related to loan agreement
Common stock issued to lender (in shares) 56,200    
Proceeds from issuance of Series E preferred stock, net of issuance costs $ 1,193 1,193
Cumulative effect of ASC 606 Adoption at Mar. 31, 2018 1,177 1,177
Restricted stock forfeited (in shares) (25,000)    
Warrants exercises (in shares) 572,858    
Warrants exercises $ 112 112
Balance (in shares) at Mar. 30, 2019 116,934 11,360,511    
Balance at Mar. 30, 2019 $ 4,806 $ 25,557 $ (28,548) $ 1,815
Shares issued from conversion of Series E preferred stock (in shares) (1,600) 160,000